ImCheck to Present New Positive Data on ICT01 Monotherapy in Hematological Cancers at ESMO 2023
15 oct. 2023 18h05 HE
|
ImCheck Therapeutics SAS
ImCheck to Present New Positive Data on ICT01 Monotherapyin Hematological Cancers at ESMO 2023 Interim data from Phase I dose escalation portion of EVICTION Phase I/IIa trialshow strong safety...
Salipro Biotech and Icosagen Launch Antibody Discovery Collaboration
10 oct. 2023 03h00 HE
|
Salipro Biotech AB
Salipro Biotech and Icosagen announce the initiation of a multi-target collaboration for the discovery and characterization of monoclonal antibodies
Antibody Drug Conjugates Market Revenue to Hit $29.6 Billion, Globally, by 2030 – Exclusive Study by The Insight Partners
09 oct. 2023 08h04 HE
|
The Insight Partners
Pune, India, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Antibody drug conjugates (ADC) are one of the fastest growing anticancer drugs. It is typically composed of a monoclonal antibody (mAbs) covalently...
Myricx Enters into Antibody License Agreement with Biocytogen
07 sept. 2023 07h00 HE
|
Myricx Bio
LONDON, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Myricx Bio (‘Myricx’), a UK biotech company focusing on the discovery and development of a completely novel class of selective cytotoxic payloads for...
Lyophilization Services for Biopharmaceuticals Market worth $3.58 Billion by 2028 - Exclusive Report by The Insight Partners
04 sept. 2023 10h08 HE
|
The Insight Partners
Pune, India, Sept. 04, 2023 (GLOBE NEWSWIRE) -- Lyophilization is a process of isolating a solid substance from a solution. It is also known as freeze-drying is a process. The process is carried by...
US Capital Global Engaged by PlantForm Corporation as Strategic Advisor on $25 Million Capital Formation
31 août 2023 07h35 HE
|
US Capital Global
San Francisco, California, USA, Aug. 31, 2023 (GLOBE NEWSWIRE) -- US Capital Global has been engaged by PlantForm Corporation (“PlantForm” or the “Company”) as its strategic financial advisor on a...
Compass Therapeutics to Participate in Upcoming Investor Events
30 août 2023 08h00 HE
|
Compass Therapeutics
BOSTON, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics...
Monopar Announces MNPR-101 Radiopharma Collaboration Agreement with National University of Singapore
11 juil. 2023 07h00 HE
|
Monopar Therapeutics Inc.
WILMETTE, Ill., July 11, 2023 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer, today...
Recombinant proteins market is projected to grow at a CAGR of 11.14% by 2033: Visiongain Reports Ltd
31 mai 2023 12h25 HE
|
Visiongain Reports Ltd
Visiongain has published a new report: Recombinant Proteins Market: Forecasts by Products & Services (Cytokines & Growth Factors (Interferons (IFNs), Interleukins (ILS), Others), Antibodies,...
Recombinant proteins market is projected to grow at a CAGR of 11.14% by 2033: Visiongain Reports Ltd
05 mai 2023 11h43 HE
|
Visiongain Reports Ltd
Visiongain has published a new report: Recombinant Proteins Market: Forecasts by Products & Services (Cytokines & Growth Factors (Interferons (IFNs), Interleukins (ILS), Others), Antibodies,...